Diptaman Chatterjee - Publications

Affiliations: 
Rush University, Chicago, IL, United States 
Area:
Neuroscience, neurodegeneration, therapeutic development, Parkinson's disease, alzheimer's disease, alpha-synuclein, misfolded protein disorders

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Killinger BA, Marshall LL, Chatterjee D, Chu Y, Bras J, Guerreiro R, Kordower JH. In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35082147 DOI: 10.1073/pnas.2114405119  0.497
2021 Chatterjee D, Marmion DJ, McBride JL, Manfredsson FP, Butler D, Messer A, Kordower JH. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9. Gene Therapy. PMID 33753910 DOI: 10.1038/s41434-021-00244-y  0.53
2020 Marmion DJ, Rutkowski AA, Chatterjee D, Hiller BM, Werner MH, Bezard E, Kirik D, McCown T, Gray SJ, Kordower JH. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease. Neurobiology of Disease. 105184. PMID 33221532 DOI: 10.1016/j.nbd.2020.105184  0.626
2019 Chatterjee D, Kordower JH. Immunotherapy in Parkinson's disease: Current status and future directions. Neurobiology of Disease. 104587. PMID 31454546 DOI: 10.1016/J.Nbd.2019.104587  0.565
2019 Chatterjee D, Sanchez DS, Quansah E, Rey NL, George S, Becker K, Madaj Z, Steiner JA, Ma J, Escobar Galvis ML, Kordower JH, Brundin P. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Journal of Parkinson's Disease. PMID 30932894 DOI: 10.3233/Jpd-191590  0.536
2018 Chatterjee D, Bhatt M, Butler D, De Genst E, Dobson CM, Messer A, Kordower JH. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model. Npj Parkinson's Disease. 4: 25. PMID 30155513 DOI: 10.1038/S41531-018-0062-4  0.676
2012 Chiu GS, Chatterjee D, Darmody PT, Walsh JP, Meling DD, Johnson RW, Freund GG. Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 13945-55. PMID 23035103 DOI: 10.1523/Jneurosci.0704-12.2012  0.458
Show low-probability matches.